Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,076-1,100 of 2,022
CompletedNCT01466439

Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
France
Sponsor
University Hospital, Caen
Condition
Schizophrenia
CompletedNCT07137572

Arts-based Social Prescribing for Mental Health

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.

SchizophreniaOtherOver 18 Years
Countries
Greece
Sponsor
KAVADIA ELENI
Condition
Schizophrenia
CompletedNCT04324944

Adapting and Examining Collaborative Decision Skills Training Among Veterans With Serious Mental Illness

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
RecruitingNCT06929442

A Preventive Behavioral Intervention for Young Adults With Psychotic Experiences

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 30 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Schizophrenia
CompletedNCT04395157

Optimizing Cognitive Remediation

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

AnxietyOtherOver 18 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Anxiety
RecruitingNCT06774430

Digital Strategies to Advance Help-Seeking Aim 1 and 2

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.

SchizophreniaOtherFrom 12 Years to 29 Years
Countries
United States
Sponsor
Columbia University
Condition
Schizophrenia
CompletedNCT05145413

A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Bulgaria, India, Japan, Poland, Romania, Serbia, United Kingdom, United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
RecruitingNCT07565428

Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand whether a medication treatment can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Minerva Neurosciences
Condition
Schizophrenia
CompletedNCT00001247

Inpatient Evaluation of Adults With Schizophrenia

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 120 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Schizophrenia
CompletedNCT05562674

Impact of VVV Group for Veterans With SMI

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
CompletedNCT00024622

PET Scanning in Parkinson s Disease

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 90 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Schizophrenia
CompletedNCT06175559

Embedded Narrative in Interactive Game Design for Improving Medication Adherence of Schizophrenia

This study exists to understand what helps cognitive behavioural therapy, a structured talking treatment, work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
China
Sponsor
Zhu Dian
Condition
Schizophrenia
RecruitingNCT07559084

Multi-target TMS for Schizophrenia Negative Symptoms

This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 16 Years to 45 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
CompletedNCT04506905

Safety, Tolerability, and Pharmacokinetics Study of Elpipodect (MK-8189) in Participants With Schizophrenia and Healthy Participants (MK-8189-011)

This study exists to better understand the safety of the medication Elpipodect and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication Elpipodect in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 80 Years
Countries
United States
Sponsor
Merck Sharp & Dohme LLC
Condition
Schizophrenia
RecruitingNCT07557381

The Effect of Game-Based Intervention on the Cognition of Schizophrenia Patients

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
Not Yet RecruitingNCT07555275

Testing a Peer-Support Group for Veterans Who Hear Voices

This study exists to understand what helps smoking support or smoking-related treatment work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether smoking support or smoking-related treatment can give earlier or clearer feedback during care.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
CompletedNCT05406440

A Study of Elpipodect (MK-8189) in Participants With Schizophrenia (MK-8189-014)

This study exists to better understand the safety of the medication Elpipodect and how manageable it feels in practice. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Merck Sharp & Dohme LLC
Condition
Schizophrenia
RecruitingNCT07557368

Effects of Gamified Rehabilitation on Cognitive and Psychosocial Outcomes in Inpatients With Schizophrenia

This study exists to understand how psychoeducation, a guided learning and support program, holds up over time after the earliest research stage. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
CompletedNCT04624243

Efficacy and Safety of Elpipodect (MK-8189) in Participants With an Acute Episode of Schizophrenia (MK-8189-008)

This study exists to see whether the medication MK-8189 can play a useful role in care. Researchers are trying to understand how people respond to the medication MK-8189 in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Bulgaria, Croatia, Japan, Latvia, Poland, Romania, Russian Federation, Serbia, South Korea, Taiwan, Ukraine, United States
Sponsor
Merck Sharp & Dohme LLC
Condition
Schizophrenia
CompletedNCT00001258

Studies of Frontal Lobe Brain Functioning in Schizophrenia

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 90 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Schizophrenia
SuspendedNCT05046353

D-serine AudRem: R33 Phase

This study exists to understand what helps a medication treatment work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
CompletedNCT05893862

A Study To Evaluate The Effect Of A Supratherapeutic Dose Of Elpipodect (MK-8189) On The QTc Interval In Participants With Schizophrenia (MK-8189-019)

This study exists to better understand the safety of the medication MK-8189 and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication MK-8189 in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
Merck Sharp & Dohme LLC
Condition
Schizophrenia